In adaptive dose finding trials, data is collected at various stages, and the dosing regimen is adjusted based on interim analyses. For example, initial cohorts of neonates might receive different doses of a medication. Based on the observed outcomes, such as efficacy and safety markers, subsequent cohorts could receive adjusted doses. This iterative process continues until the optimal dose is identified.
